Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesSurvey of vitamin D levels among post-menopausal Filipino women with osteoporosis
International Journal of Rheumatic Diseases, 08/20/09
Raso AAP et al. – Among the group of women with post-menopausal osteoporosis included in this study, only 36% had insufficient levels of 25-hydroxyvitamin D, with none of the subjects having deficient 25-hydroxyvitamin D levels. 64% had normal serum 25-hydroxyvitamin D levels – comparatively higher than that reported in the literature, suggesting the possible contribution of factors other than vitamin D deficiency in post-menopausal Filipino women with osteoporosis.
Methods- Study aims to determine the prevalence of vit D inadequacy in a group of Filipino post-menopausal women with osteoporosis
- 70 otherwise healthy post-menopausal Filipino women; diagnosed with osteoporosis by central DEXA technique
- Levels of serum 25-hydroxyvitamin D were measured using ELISA
- Mean age: 70±8 yrs, with an average of 22±10 yrs since menopause; mean BMI of 22±1 kg/m2
- Only 30% were on calcium plus vit D supplementation
- Overall serum 25-hydroxyvitamin D levels ranged from 48-128 nmol/L, with a mean of 87±20.48 nmol/L
- Serum 25-hydroxyvitamin D levels were divided as follows:
- 80-140 nmol/L (adequate)
- 25-79 nmol/L (inadequate/insufficient), and
- < 25 nmol/L (deficient)
- 64% of subjects had adequate levels while 36% had inadequate levels of 25-hydroxyvitamin D
- No subjects with deficient levels of 25-hydroxyvitamin D
- Fischer's exact test did not show an association between BMD and 25-hydroxyvitamin D
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09
Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09
Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
Journal of Clinical Endocrinology and Metabolism, 11/10/09
Sponsor
Article Search
Sponsor